SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-17-001383
Filing Date
2017-05-23
Accepted
2017-05-23 16:43:46
Documents
60
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 AMENDMENT FOR XBRL rennova_10qa1-033117.htm 10-Q/A 28611
  Complete submission text file 0001683168-17-001383.txt   2529672

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE rnva-20170331.xml EX-101.INS 456486
3 XBRL SCHEMA FILE rnva-20170331.xsd EX-101.SCH 37059
4 XBRL CALCULATION FILE rnva-20170331_cal.xml EX-101.CAL 50600
5 XBRL DEFINITION FILE rnva-20170331_def.xml EX-101.DEF 177095
6 XBRL LABEL FILE rnva-20170331_lab.xml EX-101.LAB 274014
7 XBRL PRESENTATION FILE rnva-20170331_pre.xml EX-101.PRE 241521
Mailing Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401 561-855-1626
Rennova Health, Inc. (Filer) CIK: 0000931059 (see all company filings)

IRS No.: 680370244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35141 | Film No.: 17864297
SIC: 8734 Services-Testing Laboratories